Professor Mark Rosenthal trained as a medical oncologist in Melbourne and Sydney, Australia. He received a Doctorate of Philosophy for a thesis examining the molecular genetics of colon cancer conducted at the Ludwig Institute for Cancer Research (1992-1996). He completed post-graduate training at New York University Medical Centre, New York, USA (1996-98) was a Senior Staff Specialist in the Department of Medical Oncology, Royal Melbourne Hospital (1998-2016) and Professor Director of the Department from 2006-2016. He was Chair and Chief Medical Officer of Cancer Trials Australia (2006-2016), inaugural Chair of the Cooperative Trials Group for Neuro-Oncology (2007-2017) and was the Clinical Trials Lead for the Victorian Comprehensive Cancer Centre (2016-20)

Professor Rosenthal is currently a Senior Staff Specialist in the Department of Medical Oncology at the Peter MacCallum Cancer Centre, Medical and Trials Lead for Neuro-oncology and Director of the Parkville Cancer Clinical Trials Unit. He has published over 170 peer-reviewed manuscripts and has been awarded over $30 million in competitive research grants. His major interests include neuro-oncology and clinical trials.